You just read:

Jazz Pharmaceuticals Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Disease

News provided by

Jazz Pharmaceuticals plc

11 Dec, 2014, 21:05 GMT